Current Studies

The Department of Neurology:

• Daniel Kaufer, MD

  • A Prospective, Randomized, Multi-Center, Double-Blind, 26-week, Placebo-Controlled Trial of Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia

• Silva Markovic-Plese, MD
• A 24-month double-blind, randomized, multicenter, placebo-controlled, parallel-group study comparing the efficacy and safety of 0.5 mg and 1.25 mg fingolimod (FTY720) administered orally once daily versus placebo in patients with relapsing-remitting Multiple Sclerosis